Biosynex SA (EPA:ALBIO)
1.050
-0.010 (-0.94%)
May 29, 2026, 5:35 PM CET
Biosynex Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 8.46 | 4.69 | 20.17 | 87.17 | 132.03 |
Short-Term Investments | - | 5 | 6 | - | - |
Cash & Short-Term Investments | 8.46 | 9.69 | 26.16 | 87.17 | 132.03 |
Cash Growth | -12.75% | -62.96% | -69.99% | -33.98% | 258.43% |
Accounts Receivable | 7.82 | 7.1 | 10.65 | 14.7 | 25.27 |
Other Receivables | 16.42 | 6.21 | 5.84 | 14.09 | 6.08 |
Receivables | 24.24 | 13.31 | 16.49 | 28.79 | 31.35 |
Inventory | 22.87 | 32.67 | 38.21 | 37.67 | 31.15 |
Prepaid Expenses | - | - | - | 1.43 | 1.05 |
Other Current Assets | -0 | 4.18 | 4.83 | 3.35 | 2.27 |
Total Current Assets | 55.56 | 64.39 | 91.35 | 159.61 | 198.78 |
Property, Plant & Equipment | 8.5 | 11.82 | 11.94 | 6.38 | 3.44 |
Long-Term Investments | 0.22 | 0.39 | 0.47 | 2.57 | 3.28 |
Goodwill | - | 64.13 | 91.54 | 60.91 | 46.24 |
Other Intangible Assets | 69.24 | 20.71 | 21.76 | 25.95 | 5.89 |
Long-Term Deferred Charges | - | 28.11 | 16.36 | - | - |
Other Long-Term Assets | 2.72 | 5.13 | 8.3 | 4.93 | 11.31 |
Total Assets | 136.24 | 194.69 | 241.73 | 260.34 | 268.94 |
Accounts Payable | 17.15 | 16.31 | 15.07 | 14.99 | 18.73 |
Accrued Expenses | - | 8.15 | 6.19 | 6.62 | 7.64 |
Short-Term Debt | - | 0.22 | 0.24 | 0.04 | 0.04 |
Current Portion of Long-Term Debt | - | 46.98 | - | 49.48 | 0.15 |
Current Portion of Leases | - | 0.47 | - | 1.41 | - |
Current Income Taxes Payable | - | 0.01 | 0.01 | 1.73 | 19.81 |
Current Unearned Revenue | - | 0.23 | 0.51 | 0.22 | 1.94 |
Other Current Liabilities | - | 5.33 | 9.17 | 8.36 | 12.45 |
Total Current Liabilities | 17.15 | 77.7 | 31.19 | 83.86 | 61.32 |
Long-Term Debt | 61.65 | 14.14 | 63.88 | 1.15 | 34.08 |
Long-Term Leases | - | 0.82 | 1.84 | - | 1.04 |
Long-Term Deferred Tax Liabilities | - | 6.6 | 3.48 | - | - |
Other Long-Term Liabilities | 22.5 | 14.94 | 17.02 | 8.43 | 4.69 |
Total Liabilities | 101.29 | 114.19 | 117.41 | 93.45 | 101.14 |
Common Stock | 1.88 | 1.08 | 1.08 | 1.03 | 1.11 |
Additional Paid-In Capital | 32.78 | 25.6 | 25.6 | 25.6 | 47.27 |
Retained Earnings | -58.22 | 73.8 | 55.31 | 77.08 | 130.92 |
Comprehensive Income & Other | 58.52 | -19.9 | 42.49 | 58.83 | -11.5 |
Total Common Equity | 34.95 | 80.58 | 124.48 | 162.53 | 167.81 |
Minority Interest | - | -0.08 | -0.17 | 4.37 | - |
Shareholders' Equity | 34.95 | 80.5 | 124.32 | 166.9 | 167.81 |
Total Liabilities & Equity | 136.24 | 194.69 | 241.73 | 260.34 | 268.94 |
Total Debt | 61.65 | 62.63 | 65.96 | 52.08 | 35.31 |
Net Cash (Debt) | -53.19 | -52.94 | -39.8 | 35.1 | 96.72 |
Net Cash Growth | - | - | - | -63.71% | 359.13% |
Net Cash Per Share | - | -4.92 | -3.72 | 3.41 | 9.31 |
Filing Date Shares Outstanding | - | 18.75 | 10.76 | 10.25 | 10.32 |
Total Common Shares Outstanding | - | 10.76 | 10.76 | 10.25 | 10.32 |
Working Capital | 38.42 | -13.31 | 60.16 | 75.75 | 137.45 |
Book Value Per Share | - | 7.49 | 11.57 | 15.85 | 16.26 |
Tangible Book Value | -34.29 | -4.27 | 11.18 | 75.67 | 115.67 |
Tangible Book Value Per Share | - | -0.40 | 1.04 | 7.38 | 11.21 |
Buildings | - | 3.87 | 3.13 | - | - |
Machinery | - | 34.26 | 31.4 | 10.58 | 6.37 |
Construction In Progress | - | 0 | 0.02 | 0.03 | - |